Quanta Therapeutics Presents Late-Breaking Data for QTX3034,

Quanta Therapeutics Presents Late-Breaking Data for QTX3034, a multi-KRAS inhibitor, at AACR-NCI-EORTC Conference

Quanta Therapeutics Presents Late-Breaking Data for QTX3034, a multi-KRAS inhibitor, at AACR-NCI-EORTC Conference

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Massachusetts , United States , Boston , Perry Nisen , Kelli Perkins , Heather Meeks , International Conference On Molecular , Linkedin , Molecular Targets , Cancer Therapeutics , Chief Executive Officer , Poster Session , Second Harmonic Generation , Quanta Therapeutics Heather Meeks , Contact Kelli ,